Primary hypertension resistance medicine

Abstract

The invention belongs to the field of biological medicines and relates to a primary hypertension resistance medicine. The medicine is prepared from major raw materials, namely panax notoginseng, salvia miltiorrhiza and American ginseng and has a better pressure reduction effect. The medicine can be prepared into any clinically or pharmaceutically acceptable dosage form, preferably an oral preparation.

Description

technical field [0001] The invention belongs to the field of biomedicine and relates to an anti-essential hypertension drug. Background technique [0002] Hypertension (hypertensive disease) is a chronic disease mainly manifested by continuous elevation of arterial blood pressure, which often causes lesions in the heart, brain, kidney and other important organs and has corresponding consequences. Hypertension belongs to the "headache", " Vertigo" category. The blood pressure standard recommended by the World Health Organization is: normal adult systolic blood pressure should be less than or equal to 140mmHg, diastolic blood pressure should be less than or equal to 90mmHg; systolic blood pressure between 141-159mmHg, diastolic blood pressure between 91-94mmHg, borderline hypertension. [0003] Western medicine emphasizes individualized treatment, while Chinese medicine focuses on syndrome differentiation and treatment. Western medicine treats high blood pressure and adopts ...

AI Technical Summary

Problems solved by technology

Western medicine treats high blood pressure and adopts index therapy, which often pays too much attention to an index of hypertension treatment, that is, the numerical index of blood pressure. Under allopathic treatment, it seems that the blood pressure index is normal, but in fact it is easy to repeat